During Friday’s Current trade, Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX), gain 1.77% to $72.47.
IDEXX Laboratories, Inc. (IDXX) declared the Catalyst® Total T4 Test is now accessible for both the IDEXX Catalyst Dx® Chemistry Analyzer and the IDEXX Catalyst One™ Chemistry Analyzer in North America. The Catalyst Total T4 Test enables veterinarians and technicians to provide clients with reliable and comprehensive results counting thyroid function at the point of care. Veterinarians can add total T4 to any Catalyst Dx or Catalyst One test panel, allowing for a comprehensive chemistry, electrolyte and total T4 profile in one run with a single patient sample in about 15 minutes.
Total T4 assists veterinarians more accurately diagnose and monitor thyroid disease, a common condition in both dogs and cats. The test can be used as the first part of a protocol to diagnose canine hypothyroidism and to monitor treatment. The test can assist diagnose feline hyperthyroidism and comes with a greatly expanded upper range contrast to current in-clinic offerings that is highly useful in feline thyroid cases.
IDEXX Laboratories, Inc., together with its auxiliaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, counting instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice administration systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community.
Shares of Wabash National Corporation (NYSE:WNC), declined -0.29% to $13.66, during its current trading session.
Wabash National Corporation (WNC) declared that it has accomplished an amendment to its credit agreement with a group of lenders that provides the Company’s $150.0 million, asset-based, revolving credit facility. Among other things, the amendment will i) extend the maturity of the facility from May, 2017, to June, 2020; ii) provide for an enhance in committed capital from the Company’s lenders of $25 million, to $175 million; iii) reduce interest rate margins by 25 basis points on borrowings; and, iv) reduce the unused line fee by 12.5 basis points to 25 basis points.
Wabash National Corporation designs, manufactures, and markets truck and tank trailers, intermodal equipment, and transportation related products in North America. Its Commercial Trailer Products segment provides dry van trailers under the DuraPlate, DuraPlateHD, DuraPlate, XD-35, and FreightPro trademarks; platform trailers under the Transcraft, Eagle, and Benson trademarks; refrigerated trailers under the ArcticLite trademark; and specialty products, such as converter dollies, big tire haulers, Roadrailer trailers, rail products, aftermarket component products, parts, and others, in addition to used trailers and laminated hard wood oak products.
SeaWorld Entertainment Inc (NYSE:SEAS), during its Friday’s current trading session decreased -0.40% to $17.36.
SeaWorld Entertainment, Inc. (SEAS) declared that it will release its second quarter 2015 financial results before the market opens on Thursday, August 6, 2015. In conjunction with the release, the Company has planned a conference call, which will be broadcast live over the internet, on Thursday, August 6, 2015 at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company’s website at www.seaworldentertainment.com by clicking on the Investor Relations link located on the upper right-hand corner of that page.
SeaWorld Entertainment, Inc. operates as a theme park and entertainment company in the United States. The company operates marine-life theme park under the SeaWorld brand name in Orlando, San Antonio, and San Diego; Busch Gardens theme parks, which are family-oriented destinations with foreign geographic settings in Tampa and Williamsburg; Discovery Cove marine-life theme park in Langhorne; and Sesame Place, a seasonal park in Langhorne.
Finally, Zimmer Biomet Holdings Inc (NYSE:ZBH), decreased -0.41%, to $104.42.
Zimmer Biomet Holdings, Inc. (ZBH) stated financial results for the quarter ended June 30, 2015. The Company stated second quarter net sales of $1.17 billion, a decrease of 1.3% stated and an enhance of 5.7% constant currency contrast to the second quarter of 2014. Attained revenue from Biomet amounted to $60 million, a contribution of 5.0% of the constant currency growth rate. Standalone Zimmer recorded constant currency growth in the quarter of 0.7%. Stated net loss per share for the quarter was $(0.91) and adjusted earnings per share were $1.59, an enhance of 0.6% over the preceding year period.
Net loss for the second quarter was $(158.0) million on a stated basis. On an adjusted basis, net earnings raised 2.8% over the preceding year period, to $278.7 million. Operating cash flow for the second quarter was $186.8 million.
During the quarter, the Company recorded certain non-recurring, pre-tax expenses, counting $465.0 million of charges regardingthe Biomet merger and $89.6 million of special items and certain claims. Additionally, pre-tax amortization expense in the quarter was $34.9 million.
Zimmer Biomet Holdings, Inc., together with its auxiliaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. It offers orthopaedic reconstructive devices that restore function lost due to disease or trauma in joints comprising knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons for the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the bodys natural healing process.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
